Cargando…

Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens

Cytotoxic T cell (CTL)-specific activation antigens, termed CT determinants, have been detected by monoclonal antibodies (mAb) that inhibit CTL function. At the cell surface, the CT antigens are associated with the T200 glycoproteins and two other proteins of Mr 140,000 and 85,000 and are present on...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1985
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187862/
https://www.ncbi.nlm.nih.gov/pubmed/2413157
_version_ 1782146273276592128
collection PubMed
description Cytotoxic T cell (CTL)-specific activation antigens, termed CT determinants, have been detected by monoclonal antibodies (mAb) that inhibit CTL function. At the cell surface, the CT antigens are associated with the T200 glycoproteins and two other proteins of Mr 140,000 and 85,000 and are present on a secreted protein, gp155. Periodate treatment followed by binding analysis and immunoprecipitation experiments using tunicamycin-treated cells indicated that carbohydrate is necessary for CT antigen expression. Furthermore, gp155 is secreted in the presence of tunicamycin while retaining the CT antigens, and the CT determinants are added late in T200 biosynthesis, suggesting that the CT glycans are O-linked. Finally, interleukin 2 was shown to dramatically influence the expression of the CT mAb-reactive oligosaccharides present at the CTL cell surface.
format Text
id pubmed-2187862
institution National Center for Biotechnology Information
language English
publishDate 1985
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21878622008-04-17 Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens J Exp Med Articles Cytotoxic T cell (CTL)-specific activation antigens, termed CT determinants, have been detected by monoclonal antibodies (mAb) that inhibit CTL function. At the cell surface, the CT antigens are associated with the T200 glycoproteins and two other proteins of Mr 140,000 and 85,000 and are present on a secreted protein, gp155. Periodate treatment followed by binding analysis and immunoprecipitation experiments using tunicamycin-treated cells indicated that carbohydrate is necessary for CT antigen expression. Furthermore, gp155 is secreted in the presence of tunicamycin while retaining the CT antigens, and the CT determinants are added late in T200 biosynthesis, suggesting that the CT glycans are O-linked. Finally, interleukin 2 was shown to dramatically influence the expression of the CT mAb-reactive oligosaccharides present at the CTL cell surface. The Rockefeller University Press 1985-10-01 /pmc/articles/PMC2187862/ /pubmed/2413157 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens
title Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens
title_full Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens
title_fullStr Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens
title_full_unstemmed Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens
title_short Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens
title_sort acquisition of cytotoxic t lymphocyte-specific carbohydrate differentiation antigens
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187862/
https://www.ncbi.nlm.nih.gov/pubmed/2413157